4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-054449
Chairman and CEO bought 65,000 shares at an average $0.17 ($11,300)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2022-10-19 | Purchase | +25,000 | $0.16 | $4,000 | 11,851,357 | D |
| Niihara Yutaka Chairman and CEO | 2022-10-20 | Purchase | +30,000 | $0.18 | $5,400 | 11,881,357 | D |
| Niihara Yutaka Chairman and CEO | 2022-10-21 | Purchase | +10,000 | $0.19 | $1,900 | 11,891,357 | D |
| Open-market purchases · 65,000 sh · avg $0.17 · $11,300 | |||||||
Loading xslF345X03/doc4.xml…